Investors in Abzu

Our investors empower Abzu innovation.

The support of our partners helped us to become the best in class in silico RNA Tx company.

The foundation of our future.

Driving breakthroughs in drug discovery and AI.

The trust and resources provided by our VC partners and the European Innovation Council have been pivotal in scaling our operations and research capabilities. These investments in Abzu laid the foundation for us to unlock the future of RNA Tx with explainable AI.

Abzu breakthroughs in discovery and AI

Abzu is an EIC Accelerator Grant recipient.

Achieving the pinnacle of EU funding.

In a remarkable endorsement of our ethical technology, European values, and commitment to unlocking the future of RNA therapeutics, Abzu has been honored with an EIC Accelerator Grant at its maximum funding capacity of €2.5 million.

Pre-seed and seed funding: The power of partnership.

Abzu has raised a total of € 10.2 million in funding.

Investment in Abzu is more than financial backing; it’s a belief in our potential to revolutionize the field of RNA therapeutics with our AI-driven approach.

Thanks to our VCs:

One of the most experienced Nordic venture funds, Inventure specializes in helping with talent and expansion.

Vækstfonden supports successful businesses that grow the Danish economy and green the globe.

One of the best-performing funds in Europe, Seed Capital backs Danish founders all the way to exit.

One of Denmark’s most notable early-stage investors, PSV has a knack for identifying success early.

Interested in investing in Abzu?

Then we’re interested in getting to know you.

We are discerning in our selection of investment partners. If you share our vision for unlocking the future of RNA Tx with explainable AI, then please complete the form below to start the conversation.

Entering your information above does not subscribe you to marketing emails from Abzu. It just makes it easier for us to get in touch with you. If you want to subscribe for information from Abzu, you can subscribe here.

Abzu is making headlines.

Abzu's innovative work in RNA therapeutics and explainable AI makes waves in the scientific community and beyond.

Pharmafocus
February 7, 2024

English

Don’t settle for black box: Why only explainable AI is built for pharma.

IPT
June 12, 2023

English

AI in Pharma: Balancing Reality with Possibility.

Sifted
May 5, 2023

English

20 Nordic startups to watch, according to investors.

OTS
May 9, 2022

English

Could Artificial Intelligence Provide the Key to Life Saving Medicines?

Subscribe for
notifications from Abzu.

You can opt out at any time. We’re cookieless, and our privacy policy is actually easy to read.